Adanma Ayanambakkam

7PUBLICATIONS
64CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersLiquid biopsiesAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 20, 2026
SWI/SNF Alterations Define a Chromatin-Dependent Subtype of Urothelial Carcinoma.

|Feb 09, 2026
The evolving role of adjuvant immune checkpoint inhibitors in urothelial carcinoma.

Adanma Ayanambakkam, Arnab Basu

|Dec 05, 2025
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer.

Deepak Kilari, Nicholas C Henderson, Kyra Yamamoto

|Feb 11, 2025
Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients.

Daniel Magee, Valeriy Domenyuk, Jim Abraham

|Jan 25, 2025
Clinical and Genomic Features of Androgen Indifferent Prostate Cancer.

Jack Masur, Aakrosh Ratan, Krzysztof Wierbilowicz

|Aug 18, 2017
Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20.

Adanma Ayanambakkam, Johanna A Kremer Hovinga, Sara K Vesely

Pageof 2